Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL045
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,487
Award facts
- Contract value 100% obligated
- $32,487.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 28, 2026, for the supply of RINVOQ ER 15 MG tablets in a quantity of 30 units. The contract carries a ceiling value of approximately $32,500 and employs a firm fixed-price structure with no set-aside designation, indicating competitive award. This delivery order falls under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999.9 million and extends through December 2026. That parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The contract is scheduled for ultimate completion on January 29, 2026, with performance at Amerisourcebergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. RINVOQ ER is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. This award represents a routine task order execution under the established pharmaceutical supply relationship between DLA and Cencora/Amerisourcebergen, demonstrating the vendor's role as a critical supplier of specialty medications and pharmaceutical commodities to the Department of Defense's medical supply chain and military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FL045?
SPE2DR26FL045 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FL045 worth?
The government has obligated $32,487 on SPE2DR26FL045.
Is contract SPE2DR26FL045 an order under another contract?
Yes. SPE2DR26FL045 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL045 competed?
The extent of competition for SPE2DR26FL045 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award